Antibiotic resistance is a global problem and is one of the worlds most pressing public health threats. What you may not know is that antibiotic overuse increases the development of drug–resistant germs like CA-MRSA, which is rapidly spreading worldwide. Recently, a strain of CA-MRSA called MRSA USA300 appears to be spreading rapidly in the United States.
According to the Alliance for the Prudent Use of Antibiotics (APUA), it is imperative that global attention is given now to solving the crisis of antimicrobial resistance, or else a future where drugs can no longer cure infections and killer epidemics running rampant is imminent.
I am not writing to alarm you, but to encourage you to become a vital participant in solving this problem. The solution to this problem is awareness, education and new antibiotics. So I encourage you to do some research and then spread the word to your families, readers, fans and followers.
Community-acquired soft tissue infections are commonly treated using over-the-counter ointments known as triple-antibiotic ointments (TAOs). These include Johnson & Johnson’s Neosporin (polymyxin B, bacitracin, and neomycin) and Polysporin (polymyxin B, bacitracin). The widespread use of over-the-counter antibacterial ointments bacitracin and neomycin, have lead researchers to speculate that these antibiotic creams may be contributing to the emergence of a strain of MRSA called MRSA USA300.
an excerpt from The global problem of antibiotic resistance by Thomas Gootz
Amid the recent attention justly focused on the potential problem of microbial sources for weapons of bioterrorism, it is also apparent that human pathogens frequently isolated from infections in patients from community and hospital sources have been growing more resistant to commonly used antibiotics. Much of the growth of multiple-drug-resistant (MDR) bacterial pathogens can be contributed to the overuse of broad-spectrum antimicrobial products.…The continued evolution of such a complex array of antibiotic-resistance genes presents a formidable challenge at a time when large pharmaceutical companies have scaled down their presence in the anti-infectives arena.
In my research I found that pharmaCline, a new pharmaceutical company, might have a solution with its award winning over the counter hypoallergenic Tetracycline ointments – Diabecline® and TisseclinePlus®. These antibiotics utilize innovative technology with a proprietary drug delivery technology called Site Specific Penetration Technology (SSPT™). This game-changing line of topical hypoallergenic antimicrobial drugs delivers tetracycline straight to the bacteria in the injury.
We recently had a chance to try TisseclinePlus and Diabecline antibiotic ointments. They worked well in protecting minor cuts as they healed. The Diabecline is particularly important for those with diabetes. Wounds of a diabetic take longer to heal and are prone to serious infections.
Diabecline antibiotic ointment was recently honored with the Bronze Award for 2012 Best New Pharmaceutical Product at the 25th Annual Edison Awards in New York City. The Edison Award is one of the highest accolades a company can receive for innovation in business.
- FDA-listed first-aid hypoallergenic antimicrobial ointment
- Highly concentrated formulation designed to prevent diabetics, pre-diabetics and slow healers first aid wounds from becoming more serious
- Strongest topical antibiotic available without a prescription
- Safe and effective against a wide range of disease-causing bacteria
- Helps prevent infection in minor cuts, scrapes and burns
- Rapidly penetrates wound sites to optimize natural healing using Site Specific Penetration Technology™ (SSPT)
- Works as a pharmaceutical barrier to prevent the spread of infection
To discover more about these products visit: www.pharmacline.com
I was provided with product and information by pharmaCline to write this article. All opinions are 100% my own.